CGRP receptors mediating CGRP-, adrenomedullin- and amylin-induced relaxation in porcine coronary arteries. Characterization with ‘Compound 1' (WO98/11128), a non-peptide antagonist

作者: Philip Hasbak , Anette Sams , Søren Schifter , Jenny Longmore , Lars Edvinsson

DOI: 10.1038/SJ.BJP.0704210

关键词: Calcitonin gene-related peptideInternal medicineBiologyAdrenomedullinEndocrinologyCALCRLAmylinRAMP1Receptor activity-modifying proteinReceptor Activity-Modifying Protein 1RAMP2

摘要: Calcitonin gene-related peptide (CGRP), amylin and adrenomedullin (AM) belong to the same family of peptides. Accumulating evidence indicate that calcitonin (CT) receptor, CT receptor-like receptor (CRLR) receptor-activity-modifying proteins (RAMPs) form basis all receptors in this peptides. Using reverse transcriptase–polymerase chain reaction presence mRNA sequences encoding CRLR, RAMP1 RAMP2 were demonstrated porcine left anterior descending (LAD) coronary arteries, whereas was not present. The partial shared 82–92% nucleotide identity with human sequences. The peptides αCGRP, βCGRP, AM induced relaxation pEC50 values 8.1, 6.7 6.1 M respectively. The antagonistic properties a novel non-peptide CGRP antagonist ‘Compound 1’ (WO98/11128), βCGRP8–37 proposed AM22–52 compared well-known CGRP1 αCGRP8–37. The αCGRP8–37 concentration-dependent (10−7–10−5 M) rightward shift both αCGRP βCGRP concentration-response curves. (10−6 M) had effect as (10−6 M), but less potent curves for amylin. Preincubation no significant effect. In conclusion, building blocks forming present LAD, those not. mediated vasorelaxation via receptors. No functional response detected receptor. British Journal Pharmacology (2001) 133, 1405–1413; doi:10.1038/sj.bjp.0704210

参考文章(57)
D. G. Parkes, Cardiovascular actions of adrenomedullin in conscious sheep American Journal of Physiology-heart and Circulatory Physiology. ,vol. 268, ,(1995) , 10.1152/AJPHEART.1995.268.6.H2574
A. Kanatsuka, H. Makino, H. Ohsawa, Y. Tokuyama, T. Yamaguchi, S. Yoshida, M. Adachi, Secretion of islet amyloid polypeptide in response to glucose FEBS Letters. ,vol. 259, pp. 199- 201 ,(1989) , 10.1016/0014-5793(89)81527-3
Jo W.M. Höppener, Bo Ahrén, Cornelis J.M. Lips, Islet Amyloid and Type 2 Diabetes Mellitus The New England Journal of Medicine. ,vol. 343, pp. 411- 419 ,(2000) , 10.1056/NEJM200008103430607
J. Mair, P. Lechleitner, T. Längle, C. Wiedermann, F. Dienstl, A. Saria, Plasma CGRP in acute myocardial infarction The Lancet. ,vol. 335, pp. 168- 168 ,(1990) , 10.1016/0140-6736(90)90040-C
Jeanette Longmore, Joanne E. Hogg, Peter H. Hutson, Raymond G. Hill, Effects of two truncated forms of human calcitonin-gene related peptide: implications for receptor classification European Journal of Pharmacology. ,vol. 265, pp. 53- 59 ,(1994) , 10.1016/0014-2999(94)90222-4
A. Elaine Tomlinson, David R. Poyner, Multiple receptors for calcitonin gene-related peptide and amylin on guinea-pig ileum and vas deferens British Journal of Pharmacology. ,vol. 117, pp. 1362- 1368 ,(1996) , 10.1111/J.1476-5381.1996.TB16737.X
Anders Franco-Cereceda, Hermann Henke, Jan M. Lundberg, Josef B. Petermann, Tomas Hökfelt, Jan A. Fischer, Calcitonin gene-related peptide (CGRP) in capsaicin-sensitive substance P-immunoreactive sensory neurons in animals and man: Distribution and release by capsaicin Peptides. ,vol. 8, pp. 399- 410 ,(1987) , 10.1016/0196-9781(87)90117-3
Hiroaki Kano, Masakazu Kohno, Kenichi Yasunari, Koji Yokokawa, Takeshi Horio, Miwako Ikeda, Mieko Minami, Takao Hanehira, Tadanao Takeda, Junichi Yoshikawa, Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells. Journal of Hypertension. ,vol. 14, pp. 209- 213 ,(1996) , 10.1097/00004872-199602000-00009
O S. Opgaard, S Gulbenkian, A Bergdahl, C. Barroso, N C. Andrade, J. Polak, J Q. e Melo, L Edvinsson, Innervation of human epicardial coronary veins: immunohistochemistry and vasomotility Cardiovascular Research. ,vol. 29, pp. 463- 468 ,(1995) , 10.1016/S0008-6363(96)88520-8